Free Trial
NASDAQ:MESO

Mesoblast (MESO) Stock Price, News & Analysis

Mesoblast logo
$15.56 +0.56 (+3.73%)
Closing price 04:00 PM Eastern
Extended Trading
$15.62 +0.05 (+0.35%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Mesoblast Stock (NASDAQ:MESO)

Key Stats

Today's Range
$15.23
$15.67
50-Day Range
$10.45
$16.98
52-Week Range
$6.00
$22.00
Volume
373,576 shs
Average Volume
213,413 shs
Market Capitalization
$1.99 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Buy

Company Overview

Mesoblast Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

MESO MarketRank™: 

Mesoblast scored higher than 30% of companies evaluated by MarketBeat, and ranked 783rd out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Mesoblast has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Mesoblast has a consensus price target of $18.00, representing about 15.7% upside from its current price of $15.56.

  • Amount of Analyst Coverage

    Mesoblast has only been the subject of 2 research reports in the past 90 days.

  • Read more about Mesoblast's stock forecast and price target.
  • Earnings Growth

    Earnings for Mesoblast are expected to grow in the coming year, from ($0.70) to ($0.32) per share.

  • Price to Book Value per Share Ratio

    Mesoblast has a P/B Ratio of 3.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.86% of the outstanding shares of Mesoblast have been sold short.
  • Short Interest Ratio / Days to Cover

    Mesoblast has a short interest ratio ("days to cover") of 10.8, which indicates bearish sentiment.
  • Change versus previous month

  • Dividend Yield

    Mesoblast does not currently pay a dividend.

  • Dividend Growth

    Mesoblast does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.86% of the outstanding shares of Mesoblast have been sold short.
  • Short Interest Ratio / Days to Cover

    Mesoblast has a short interest ratio ("days to cover") of 10.8, which indicates bearish sentiment.
  • Change versus previous month

  • News Sentiment

    Mesoblast has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Mesoblast this week, compared to 3 articles on an average week.
  • Search Interest

    Only 3 people have searched for MESO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Mesoblast to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Mesoblast insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.80% of the stock of Mesoblast is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 1.43% of the stock of Mesoblast is held by institutions.

  • Read more about Mesoblast's insider trading history.
Receive MESO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesoblast and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MESO Stock News Headlines

IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
Mesoblast (NASDAQ:MESO) Shares Gap Down - What's Next?
See More Headlines

MESO Stock Analysis - Frequently Asked Questions

Mesoblast's stock was trading at $19.80 at the start of the year. Since then, MESO shares have decreased by 21.4% and is now trading at $15.56.

Mesoblast Limited (NASDAQ:MESO) announced its quarterly earnings results on Wednesday, August, 30th. The company reported ($0.28) EPS for the quarter, beating analysts' consensus estimates of ($0.34) by $0.06. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2 million.
Read the conference call transcript
.

Shares of Mesoblast reverse split on Friday, January 5th 2024.The 1-2 reverse split was announced on Friday, January 5th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, January 5th 2024. An investor that had 100 shares of stock prior to the reverse split would have 50 shares after the split.

Mesoblast (MESO) raised $69 million in an IPO on Friday, November 13th 2015. The company issued 5,700,000 shares at $12.10 per share. J.P. Morgan and Credit Suisse served as the underwriters for the IPO and Maxim Group and Ladenburg Thalmann were co-managers.

Top institutional investors of Mesoblast include Summit X LLC (0.16%), Group One Trading LLC, Marex Group plc and Lazari Capital Management Inc. (0.04%).

Shares of MESO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesoblast investors own include NVIDIA (NVDA), Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), Meta Platforms (META), CRISPR Therapeutics (CRSP) and Corbus Pharmaceuticals (CRBP).

Company Calendar

Last Earnings
8/30/2023
Today
9/10/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MESO
Previous Symbol
OTCMKTS:MBLTY
CIK
1345099
Employees
80
Year Founded
2004

Price Target and Rating

High Price Target
$24.00
Low Price Target
$12.00
Potential Upside/Downside
+15.7%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
1.99
Quick Ratio
1.77

Sales & Book Value

Annual Sales
$17.20 million
Price / Sales
115.80
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.67 per share
Price / Book
3.33

Miscellaneous

Outstanding Shares
128,000,000
Free Float
103,934,000
Market Cap
$1.99 billion
Optionable
Optionable
Beta
2.26

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:MESO) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners